课题基金 / 基金详情

Pathogenesis-based treatment of type 1 diabetes

Pathogenesis-based treatment of type 1 diabetes
1型糖尿病的发病机制治疗
批准号:
nhmrc : 1037321
负责人:
A/Pr Helen Thomas
金额:
$720.7万
依托单位国家:
澳大利亚
项目类别:
Program Grants
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 2017-12-31

项目摘要

项目成果

A/Pr Helen Thomas的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
At least 6 young Australians are diagnosed each day with type 1 diabetes. This Program aims to change the way type 1 diabetes is managed by proactively treating its underlying mechanisms. We will develop safer and more effective immune therapies, develop islet transplantation, look for better markers of disease, and identify ways to preserve insulin-producing cells. The Program aims to propel type 1 diabetes research forward to reach the goals of prevention and cure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Repurposing JAK inhibitors to treat type 1 diabetes
Repurposing JAK inhibitors to treat type 1 diabetes
  • 批准号:
    nhmrc : GNT1145507
  • 项目类别:
    Project Grants
  • 资助金额:
    $94.79万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Helen Thomas
  • 依托单位:
Prevention of pancreatic beta cell destruction in diabetes
Glucose toxicity-induced activation of the Bcl-2-regulated apoptotic pathway in pancreatic beta cells
国内基金
海外基金
Data-driven Recommendation System Construction of an Online Medical Platform Based on the Fusion of Information
Incentive and governance schenism study of corporate green washing behavior in China: Based on an integiated view of econfiguration of environmental authority and decoupling logic
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    YU BYUNGJUN
  • 依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI ZHANG
  • 依托单位:
含Re、Ru先进镍基单晶高温合金中TCP相成核—生长机理的原位动态研究
  • 批准号:
    52301178
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    夏万顺
  • 依托单位: